L10.8: Pemfigus Lainnya (Other Pemphigus) - Tinjauan Komprehensif

Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's Principles of Internal Medicine, 20th Edition. McGraw-Hill Education; 2018.

James WD, Elston DM, Treat JR, Rosenbach MA, Neuhaus IM. Andrews' Diseases of the Skin: Clinical Dermatology, 13th Edition. Elsevier; 2020.

Bolognia J, Schaffer JV, Cerroni L. Dermatology, 4th Edition. Elsevier; 2017.

Amagai M, Stanley JR. Desmoglein as a target in skin disease and beyond. J Invest Dermatol. 2012;132(3):776-784.

Harman KE, Albert S, Black MM. Guidelines for the management of pemphigus vulgaris. Br J Dermatol. 2003;149(5):926-937.

Joly P, Richard C, Gilbert D, et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol. 2000;43(4):619-626.

Zone JJ, Taylor TB, Meyer LJ, Petersen MJ. The 96-well plate assay for IgA pemphigus. J Invest Dermatol. 1996;106(5):1013-1016.

Hurmaz H, Danescu S, Boer-Auer A. Successful treatment of IgA pemphigus with dapsone. J Eur Acad Dermatol Venereol. 2015;29(6):1233-1235.

WHO. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). World Health Organization; 2019.

Menter A, Gottlieb A, Elliott Farber A, et al. American Academy of Dermatology guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2008;58(5):826-850.